Human papillomavirus (HPV) is the necessary cause of cervical cancer and responsible for ~90% of anal, 78% of vaginal, 50% of penile, and 25% of vulvar cancers. In Costa Rica (CR), few studies have examined incidence trends of these cancers. We assessed age‐standardized incidence rates (ASIRs) and trends of invasive an...
Loretto J. Carvajal, J. Shing, Juan C. Vanegas et al.· International Journal of Can...· 0 citations
Stage at diagnosis is informed by when cancer is detected and one of the strongest prognostic factors for survival. Disparities in diagnosis stage result from inequities in access to quality medical care, which disproportionately impact racial and ethnic minoritized populations and people in less urban areas....
Beth J. Maclin, A. Cho, Melissa Buffalo et al.· Cancer Epidemiology, Biomark...· 0 citations
Breast cancer survivors have an increased risk of developing contralateral breast cancer (CBC), with approximately 1 in 30 developing CBC within 10 years of their initial diagnosis. However, few U.S. studies have examined CBC risk by racial and ethnic differences or by estrogen receptor (ER) subtype of the contra...
Michelle O. Sodipo, Jacqueline B. Vo, J. Shing et al.· Cancer Epidemiology, Biomark...· 0 citations
Black women had consistently high ER+ and ER- breast cancer incidence-based MRs compared with all racial and ethnic groups regardless of residence at diagnosis, and patterns were largely consistent by county-level population density and income for racial and ethnic groups.
Stephanie T. Y. Ho, Paloma R. Mitra, Hyokyoung G. Hong et al.· Cancer Epidemiology, Biomark...· 0 citations
Increasing survival for head and neck cancer (HNC) patients raises concerns about risk of cardiovascular disease (CVD), due to shared risk factors (e.g., smoking, heavy alcohol use) and long-term cardiotoxic effects of cancer and its treatments. HNC survivors are more likely develop and die of CVD compared with t...
Jacqueline B. Vo, Isha Patel, K. Taparra et al.· Cancer Epidemiology, Biomark...· 0 citations
Cardiovascular disease (CVD) is a leading cause of morbidity and non-cancer mortality among U.S. breast cancer survivors. Differences in risk factors and receipt of cardiotoxic cancer treatment may contribute to disproportionate cardiovascular outcomes by race and ethnicity. This scoping review comprehensively ev...
Isha Patel, La-Urshalar Brock, Yue-Han Wang et al.· Cancer Epidemiology, Biomark...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.